Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. Sep 1993; 68(3): 605–609.
PMCID: PMC1968398

Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.

Abstract

Incidence and prognostic factors of primary carcinoma of the Fallopian tube were studied in a retrospective multi-centre analysis of 115 women during the period 1980 to 1990. Data of 28 departments (university as well as general hospitals) were included in the present study which was designed to evaluate the current diagnosis and treatment of carcinoma of the Fallopian tube in Austria, and to compare the results with those from the literature. Stages were classified according to the modified FIGO-system for ovarian cancer; grading followed the criteria of Hu et al. (1950). The mean age of the patients was 62.5 years. Forty-seven (40.9%) tumours were found to be in stage I, 20 (17.4%) in stage II, 34 (29.6%) in stage III, and 14 (12.1%) in stage IV. In 82 patients, the tumour could be completely removed. The surgical method applied in 95 cases was removal of the uterus, the adnexa, and/or the omentum, or lymph nodes. Postoperatively patients underwent adjuvant therapy which was either irradiation (n = 40; 34.8%), or chemotherapy (n = 49; 42.6%); 26 women (22.6%) had no therapy after operation. The 5-year survival rate for all stages was 36.5%. In stages I and II the 5-year survival was 50.8% compared to 13.6% in stages III and IV. FIGO-stage I and II and a residual tumour less than 2 cm in advanced disease had a prognostically favourable impact, which was proven in univariate as well as multivariate analysis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (880K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol. 1983 Feb;61(2):189–193. [PubMed]
  • Böhme M, Donat H, Baumann D. Das primäre Tubenkarzinom. Zentralbl Gynakol. 1992;114(5):244–248. [PubMed]
  • Denham JW, Maclennan KA. The management of primary carcinoma of the fallopian tube. Experience of 40 cases. Cancer. 1984 Jan 1;53(1):166–172. [PubMed]
  • Dodson MG, Ford JH, Jr, Averette HE. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol. 1970 Dec;36(6):935–939. [PubMed]
  • Eddy GL, Copeland LJ, Gershenson DM, Atkinson EN, Wharton JT, Rutledge FN. Fallopian tube carcinoma. Obstet Gynecol. 1984 Oct;64(4):546–552. [PubMed]
  • Engeler V, Reinisch E, Schreiner WE. Das primäre Tuben-karzinom--Eine klinische Studie an 37 Patientinnen. Geburtshilfe Frauenheilkd. 1981 May;41(5):325–329. [PubMed]
  • GREEN TH, Jr, SCULLY RE. Tumors of the fallopian tube. Clin Obstet Gynecol. 1962 Sep;5:886–906. [PubMed]
  • Hanton EM, Malkasian GD, Jr, Dahlin DC, Pratt JH. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1966 Mar 15;94(6):832–839. [PubMed]
  • HU CY, TAYMOR ML, HERTIG AT. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1950 Jan;59(1):58–illust. [PubMed]
  • Kubista E, Kupka S. Klinische Problematik, Therapie und Prophylaxe des primären Tubenkarzinoms. Geburtshilfe Frauenheilkd. 1977 Dec;37(12):1044–1049. [PubMed]
  • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed]
  • Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec;76(6):1020–1024. [PubMed]
  • McMurray EH, Jacobs AJ, Perez CA, Camel HM, Kao MS, Galakatos A. Carcinoma of the fallopian tube. Management and sites of failure. Cancer. 1986 Nov 1;58(9):2070–2075. [PubMed]
  • Pakisch B, Poschauko J, Stücklschweiger G, Poier E, Lahousen M, Pickel H, Kohek P, Klug P, Hackl A. Die Behandlung des primären Karzinoms der Tuba Fallopii. Geburtshilfe Frauenheilkd. 1990 Aug;50(8):593–596. [PubMed]
  • Pfeiffer P, Mogensen H, Amtrup F, Honore E. Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period. Acta Oncol. 1989;28(1):7–11. [PubMed]
  • Podratz KC, Podczaski ES, Gaffey TA, O'Brien PC, Schray MF, Malkasian GD., Jr Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1986 Jun;154(6):1319–1326. [PubMed]
  • Raju KS, Barker GH, Wiltshaw E. Primary carcinoma of the fallopian tube. Report of 22 cases. Br J Obstet Gynaecol. 1981 Nov;88(11):1124–1129. [PubMed]
  • Roberts JA, Lifshitz S. Primary adenocarcinoma of the fallopian tube. Gynecol Oncol. 1982 Jun;13(3):301–308. [PubMed]
  • Schiller HM, Silverberg SG. Staging and prognosis in primary carcinoma of the fallopian tube. Cancer. 1971 Aug;28(2):389–395. [PubMed]
  • Sevelda P, Rosen A, Denison U, Barrada M, Spona J, Salzer H. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels? Gynecol Oncol. 1991 Nov;43(2):154–158. [PubMed]
  • Tamimi HK, Figge DC. Adenocarcinoma of the uterine tube: potential for lymph node metastases. Am J Obstet Gynecol. 1981 Sep 15;141(2):132–137. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...